Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Musa acuminata fruit refers to the fruit of the banana plant. Extracts from its fruit and fruit peels have been investigated for various applications. The fruit extracts serve as sustainable carbon sources for bacterial cellulose production, with glucose identified as a primary carbohydrate. Its fruit peel extracts have been studied for their potential use in traditional medicine for conditions like hypertension and other cardiovascular diseases. Additionally, these extracts have been explored as photosensitizers in dye-sensitized solar cells, where flavonoids like gallocatechin have been identified. Studies have shown that certain cultivars, such as the Saro cultivar, may exhibit nephrotoxic effects when administered as aqueous fruit peel extracts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Musa acuminata fruit.